M&A Deal Summary |
|
---|---|
Date | 2007-01-01 |
Target | Cerexa |
Sector | Life Science |
Buyer(s) | Forest Laboratories |
Sellers(s) |
EGS Healthcare Capital Partners
Montreux Equity Partners |
Deal Type | Add-on Acquisition |
Deal Value | 480M USD |
SEARCH BY
Try For Free 7-Day Free Trial
Category | Company |
---|---|
Founded | 1956 |
Sector | Medical Products |
Employees | 5,800 |
Revenue | 3.1B USD (2013) |
Forest Laboratories, Inc. develops, manufactures, and sells branded forms of ethical drug products in the United States and Europe.
DEAL STATS | # |
---|---|
Overall | 1 of 4 |
Sector (Life Science) | 1 of 2 |
Type (Add-on Acquisition) | 1 of 4 |
State (California) | 1 of 1 |
Country (United States) | 1 of 3 |
Year (2007) | 1 of 1 |
Size (of disclosed) | 4 of 4 |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2011-04-14 |
Clinical Data
Newton, Massachusetts, United States Clinical Data, a specialty pharmaceutical company focused on the development of first-in-class and best-in-category therapeutics. |
Buy | $1.2B |
Category | Private Equity Firm |
---|---|
Founded | 1999 |
PE ASSETS | 135M USD |
Size | Small |
Type | Sector Focused |
EGS Healthcare Capital Partners is a specialist private equity firm focused on investments in the healthcare sector. Specific areas of interest include biotechnology, specialty pharmaceutical, and medical device companies. EGS typically invests in late-stage private and emerging public companies with promising products. EGS prefers to lead investments with an initial commitment of $5 million per transaction. The Firm generally seeks board representation. EGS Healthcare Partner was formed in 1999 and is based in Rowayton, Connecticut.
DEAL STATS | # |
---|---|
Overall | 4 of 7 |
Sector (Life Science) | 3 of 5 |
Type (Add-on Acquisition) | 2 of 3 |
State (California) | 2 of 3 |
Country (United States) | 4 of 6 |
Year (2007) | 1 of 3 |
Size (of disclosed) | 1 of 3 |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2005-06-30 |
Peninsula Pharmaceuticals
Alameda, California, United States Peninsula Pharmaceuticals, Inc. is a pharmaceutical company focuses on licensing, developing, and commercializing anti-infective products for the treatment of life-threatening infections. |
Sell | $245M |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2007-04-20 |
Endius
Plainville, Massachusetts, United States Endius, Inc. is a privately held medical device company that had developed and commercialized a minimally invasive access system for spine surgery. |
Sell | $80M |
Montreux Equity Partners is a growth investment firm focused on investing in commercial stage companies with category leading products, technologies, and services. Montreux Equity Partners looks to invest $10 to $20 million in fast growing companies with $5 to $50 million in revenue. Montreux Equity Partners was formed in 1993 and is headquartered in San Francisco, California.
DEAL STATS | # |
---|---|
Overall | 7 of 24 |
Sector (Life Science) | 3 of 9 |
Type (Add-on Acquisition) | 7 of 15 |
State (California) | 7 of 22 |
Country (United States) | 7 of 24 |
Year (2007) | 1 of 4 |
Size (of disclosed) | 1 of 6 |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2006-11-22 |
OREXIGEN Therapeutics
La Jolla, California, United States Orexigen Therapeutics, Inc. is a bio-pharmaceutical company focuses on the treatment of obesity. The Company's lead product candidate is Contrave, which has completed Phase III clinical trials and for which a New Drug Application has been submitted and reviewed by the FDA. |
Buy | $30M |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2007-02-08 |
NeurogesX
San Mateo, California, United States NeurogesX, Inc. is a specialty pharmaceutical company focused on developing and commercializing a portfolio of novel non-opioid, pain management therapies to address unmet medical needs and improve patients' quality of life. NeurogesX was founded in 1998 and is based in San Mateo, California. |
Sell | - |